• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

旧貌换新颜:对糖尿病足微生物群的见解。

What's old is new again: Insights into diabetic foot microbiome.

作者信息

Rajab Azza A H, Hegazy Wael A H

机构信息

Department of Microbiology and Immunology, Faculty of Pharmacy, Zagazig University, Zagzig 44511, Egypt.

出版信息

World J Diabetes. 2023 Jun 15;14(6):680-704. doi: 10.4239/wjd.v14.i6.680.

DOI:10.4239/wjd.v14.i6.680
PMID:37383589
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10294069/
Abstract

Diabetes is a chronic disease that is considered one of the most stubborn global health problems that continues to defy the efforts of scientists and physicians. The prevalence of diabetes in the global population continues to grow to alarming levels year after year, causing an increase in the incidence of diabetes complications and health care costs all over the world. One major complication of diabetes is the high susceptibility to infections especially in the lower limbs due to the immunocompromised state of diabetic patients, which is considered a definitive factor in all cases. Diabetic foot infections continue to be one of the most common infections in diabetic patients that are associated with a high risk of serious complications such as bone infection, limb amputations, and life-threatening systemic infections. In this review, we discussed the circumstances associated with the high risk of infection in diabetic patients as well as some of the most commonly isolated pathogens from diabetic foot infections and the related virulence behavior. In addition, we shed light on the different treatment strategies that aim at eradicating the infection.

摘要

糖尿病是一种慢性病,被认为是最顽固的全球性健康问题之一,持续挑战着科学家和医生的努力。全球人口中糖尿病的患病率年复一年地持续增长至惊人水平,导致全球糖尿病并发症的发病率和医疗保健成本不断增加。糖尿病的一个主要并发症是患者易受感染,尤其是下肢,因为糖尿病患者处于免疫功能低下状态,这在所有病例中都被视为一个决定性因素。糖尿病足感染仍然是糖尿病患者中最常见的感染之一,与严重并发症如骨感染、肢体截肢和危及生命的全身感染的高风险相关。在本综述中,我们讨论了糖尿病患者感染高风险相关的情况,以及一些糖尿病足感染中最常分离出的病原体及其相关毒力行为。此外,我们还阐述了旨在根除感染的不同治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36da/10294069/f4e64c7311f1/WJD-14-680-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36da/10294069/4fe0657cf67d/WJD-14-680-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36da/10294069/8c332b897b0b/WJD-14-680-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36da/10294069/cfce455431ba/WJD-14-680-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36da/10294069/f4e64c7311f1/WJD-14-680-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36da/10294069/4fe0657cf67d/WJD-14-680-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36da/10294069/8c332b897b0b/WJD-14-680-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36da/10294069/cfce455431ba/WJD-14-680-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36da/10294069/f4e64c7311f1/WJD-14-680-g004.jpg

相似文献

1
What's old is new again: Insights into diabetic foot microbiome.旧貌换新颜:对糖尿病足微生物群的见解。
World J Diabetes. 2023 Jun 15;14(6):680-704. doi: 10.4239/wjd.v14.i6.680.
2
Diagnosis and treatment of diabetic foot infections.糖尿病足感染的诊断与治疗
Plast Reconstr Surg. 2006 Jun;117(7 Suppl):212S-238S. doi: 10.1097/01.prs.0000222737.09322.77.
3
Spectrum of bacteria associated with diabetic foot ulcer and biofilm formation: A prospective study.与糖尿病足溃疡相关的细菌谱及生物膜形成:一项前瞻性研究。
Australas Med J. 2015 Sep 30;8(9):280-5. doi: 10.4066/AMJ.2015.2422. eCollection 2015.
4
Co-therapy using lytic bacteriophage and linezolid: effective treatment in eliminating methicillin resistant Staphylococcus aureus (MRSA) from diabetic foot infections.联合使用溶菌噬菌体和利奈唑胺:有效治疗糖尿病足感染中的耐甲氧西林金黄色葡萄球菌(MRSA)。
PLoS One. 2013;8(2):e56022. doi: 10.1371/journal.pone.0056022. Epub 2013 Feb 13.
5
Treatment of diabetic foot ulcer: an overview strategies for clinical approach.糖尿病足溃疡的治疗:临床处理的概述策略
Curr Diabetes Rev. 2006 Nov;2(4):431-47. doi: 10.2174/1573399810602040431.
6
Susceptibility patterns of Staphylococcus aureus biofilms in diabetic foot infections.糖尿病足感染中金黄色葡萄球菌生物膜的药敏模式
BMC Microbiol. 2016 Jun 23;16(1):119. doi: 10.1186/s12866-016-0737-0.
7
Bacteriological Profile of Diabetic Foot Ulcers and Detection of Methicillin-Resistant Staphylococcus aureus and Extended-Spectrum β-Lactamase Producers in a Tertiary Care Hospital.三级护理医院中糖尿病足溃疡的细菌学特征以及耐甲氧西林金黄色葡萄球菌和产超广谱β-内酰胺酶菌株的检测
Cureus. 2021 Dec 22;13(12):e20596. doi: 10.7759/cureus.20596. eCollection 2021 Dec.
8
[Infections in diabetic patients--a two-year experience from the Diabetic Foot Unit at Wolfson Medical Center].[糖尿病患者的感染——来自沃尔夫森医疗中心糖尿病足病科的两年经验]
Harefuah. 2008 Mar;147(3):197-9, 279.
9
The bacteriology of diabetic foot ulcers and infections and incidence of Small Colony Variants.糖尿病足溃疡和感染的细菌学和小菌落变异的发生率。
J Med Microbiol. 2023 Jun;72(6). doi: 10.1099/jmm.0.001716.
10
Emergence of community-acquired methicillin-resistant Staphylococcus aureus EMRSA-15 clone as the predominant cause of diabetic foot ulcer infections in Portugal.社区获得性耐甲氧西林金黄色葡萄球菌 EMRSA-15 克隆的出现成为葡萄牙糖尿病足溃疡感染的主要原因。
Eur J Clin Microbiol Infect Dis. 2020 Jan;39(1):179-186. doi: 10.1007/s10096-019-03709-6. Epub 2019 Oct 10.

引用本文的文献

1
Reviving Furosemide as a Metallo-β-Lactamase Inhibitor against MDR .将速尿重新用作抗多重耐药性金属β-内酰胺酶抑制剂
J Microbiol Biotechnol. 2025 Aug 7;35:e2506023. doi: 10.4014/jmb.2506.06023.
2
Innovative Non-antibiotic Strategies for Combating Methicillin-Resistant Staphylococcus aureus in Diabetic Foot Infections.对抗糖尿病足感染中耐甲氧西林金黄色葡萄球菌的创新非抗生素策略
Curr Microbiol. 2025 Jul 14;82(9):384. doi: 10.1007/s00284-025-04349-0.
3
Phenotypic and genotypic characteristics of macrolide, lacosamide, and streptogramin resistance in clinically resistant Streptococci and their correlation with reduced biocide susceptibility.

本文引用的文献

1
Biofilm Lifestyle in Recurrent Urinary Tract Infections.复发性尿路感染中的生物膜生活方式
Life (Basel). 2023 Jan 4;13(1):148. doi: 10.3390/life13010148.
2
Hiring of the Anti-Quorum Sensing Activities of Hypoglycemic Agent Linagliptin to Alleviate the Pathogenesis.利用降糖药物利格列汀的抗群体感应活性来减轻发病机制。
Microorganisms. 2022 Dec 12;10(12):2455. doi: 10.3390/microorganisms10122455.
3
Characterization of the Anti-Biofilm and Anti-Quorum Sensing Activities of the β-Adrenoreceptor Antagonist Atenolol against Gram-Negative Bacterial Pathogens.
临床耐药链球菌中对大环内酯类、拉科酰胺和链阳菌素耐药的表型和基因型特征及其与杀菌剂敏感性降低的相关性。
BMC Med. 2025 May 13;23(1):281. doi: 10.1186/s12916-025-04097-9.
4
Reprofiling lamivudine as an antibiofilm and anti-pathogenic agent against Pseudomonas aeruginosa.将拉米夫定重新定位为抗铜绿假单胞菌生物膜和抗病原体的药物。
AMB Express. 2025 Feb 22;15(1):33. doi: 10.1186/s13568-025-01835-3.
5
Sulforaphane Is Not Only a Food Supplement: It Diminishes the Intracellular Survival and Colonization of .萝卜硫素不仅是一种食品补充剂:它还能减少……的细胞内存活和定植。 (原文此处不完整)
ACS Omega. 2025 Jan 16;10(3):2969-2977. doi: 10.1021/acsomega.4c09408. eCollection 2025 Jan 28.
6
Celastrol boosts fluconazole efficacy against vaginal candidiasis: in vitro and in vivo evidence.雷公藤红素增强氟康唑对阴道念珠菌病的疗效:体外和体内证据
AMB Express. 2025 Jan 29;15(1):18. doi: 10.1186/s13568-025-01824-6.
7
Novel antimicrobial strategies for diabetic foot infections: addressing challenges and resistance.糖尿病足感染的新型抗菌策略:应对挑战与耐药性
Acta Diabetol. 2025 Mar;62(3):303-321. doi: 10.1007/s00592-024-02438-3. Epub 2025 Jan 6.
8
Microbial profile of diabetic foot osteomyelitis from the northwest of England.英格兰西北部糖尿病足骨髓炎的微生物谱
Clin Diabetes Endocrinol. 2024 Nov 9;10(1):35. doi: 10.1186/s40842-024-00193-6.
9
Cilostazol is a promising anti-pseudomonal virulence drug by disruption of quorum sensing.西洛他唑是一种通过破坏群体感应来发挥作用的有前景的抗铜绿假单胞菌毒力药物。
AMB Express. 2024 Aug 1;14(1):87. doi: 10.1186/s13568-024-01740-1.
10
Arctigenin from Burdock Root Exhibits Potent Antibacterial and Anti-Virulence Properties against .牛蒡根中的牛蒡子苷元具有很强的抗菌和抗毒力特性。
J Microbiol Biotechnol. 2024 Aug 28;34(8):1642-1652. doi: 10.4014/jmb.2403.03003. Epub 2024 Jun 17.
β-肾上腺素受体拮抗剂阿替洛尔抑制革兰氏阴性菌生物膜形成和群体感应的作用特征。
Int J Mol Sci. 2022 Oct 28;23(21):13088. doi: 10.3390/ijms232113088.
4
Controlling of Bacterial Virulence: Evaluation of Anti-Virulence Activities of Prazosin against .细菌毒力的控制:哌唑嗪抗毒力活性对……的评估
Antibiotics (Basel). 2022 Nov 9;11(11):1585. doi: 10.3390/antibiotics11111585.
5
Hyperglycemia in Diabetic Skin Infections Promotes Virulence Factor Aureolysin: Visualization by Molecular Imaging.糖尿病皮肤感染中的高血糖促进了毒力因子金葡球菌素的表达:分子影像学可视化。
ACS Sens. 2022 Nov 25;7(11):3416-3421. doi: 10.1021/acssensors.2c01565. Epub 2022 Nov 9.
6
Silencing of Pathogenesis: Atenolol Acquires Efficient Anti-Virulence Activities.致病机制的沉默:阿替洛尔获得高效抗毒力活性。
Microorganisms. 2022 Oct 6;10(10):1976. doi: 10.3390/microorganisms10101976.
7
Muting Bacterial Communication: Evaluation of Prazosin Anti-Quorum Sensing Activities against Gram-Negative Bacteria , , and .抑制细菌通讯:哌唑嗪对革兰氏阴性菌、和的群体感应抑制活性评估
Biology (Basel). 2022 Sep 13;11(9):1349. doi: 10.3390/biology11091349.
8
A review on contemporary nanomaterial-based therapeutics for the treatment of diabetic foot ulcers (DFUs) with special reference to the Indian scenario.关于当代基于纳米材料的糖尿病足溃疡(DFUs)治疗方法的综述,特别提及印度的情况。
Nanoscale Adv. 2022 Apr 11;4(11):2367-2398. doi: 10.1039/d1na00859e. eCollection 2022 May 31.
9
Clinical profile and spectrum of bacteriuria in patients with diabetes: An analytical study.糖尿病患者菌尿症的临床特征与范围:一项分析性研究。
J Family Med Prim Care. 2022 Jun;11(6):3190-3195. doi: 10.4103/jfmpc.jfmpc_1779_21. Epub 2022 Jun 30.
10
Amphotericin B-PEG Conjugates of ZnO Nanoparticles: Enhancement Antifungal Activity with Minimal Toxicity.氧化锌纳米颗粒的两性霉素B-聚乙二醇缀合物:增强抗真菌活性并将毒性降至最低
Pharmaceutics. 2022 Aug 7;14(8):1646. doi: 10.3390/pharmaceutics14081646.